Novartis can’t have separate trial on blood pressure drug invalidity claim

Intellectual Property 2023-08-18 10:04 pm By Cindy Cameronne | Sydney

Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.